ALLIE NUSSBAUM: Open Payments
NPI 1366057267 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 16 payments from 10 companies in 2025. Trend: 2023 $78 · 2024 $177 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| GENZYME CORPORATION | 2 | $66 |
| Daiichi Sankyo Inc. | 2 | $54 |
| TAIHO ONCOLOGY, INC. | 2 | $52 |
| Syndax Pharmaceuticals, Inc. | 2 | $44 |
| SOBI, INC | 1 | $26 |
| Geron Corporation | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
| EMD Serono, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: SARCLISA, LONSURF, REVUFORJ, CREON, Enhertu, Vonjo, RYTELO, Vanflyta.
Industry payments across NY — which companies pay providers there.
